Inflammatory Diseases of Blood Vessels

Description

In recent years, considerable progress has been made in understanding the vasculitic diseases, largely due to the introduction of effective treatments for diseases that were once uniformly fatal, the conduct of structured clinical studies, and advances in immunology and molecular biology. Despite these achievements, the vasculitic diseases continue to be associated with morbidity and mortality from chronic organ damage, relapses, and the side effects of treatment. Investigations into the mechanisms of vascular inflammation may lead to a better comprehension of the pathogenesis of vasculitic diseases and to treatment that is more effective and less toxic. These areas of promising research, together with current knowledge about the vasculitic diseases, are extensively examined in this new edition, which is designed to provide a comprehensive overview of the science and clinical consequences of vascular inflammation in health and disease.

Table of Contents

• List of Contributors
• Preface

Section I. Biology of Blood Vessels and Mechanisms of Vascular Inflammation

• 1. Vascular Development
  Domenico Ribatti and Enrico Crivellato
• 2. Vascular Repair
  Christian Troidl, Kerstin Troidl, Georg Jung, Thomas Schmitz-Rixen and Wolfgang Schaper
• 3. Leukocyte Trafficking
  Braedon McDonald and Paul Kubes
• 4. Dendritic Cells and Vascular Inflammation
  Cornelia M. Weyand
• 5. T Cells and Vascular Inflammation
  Jörg J. Goronzy
• 6. Autoantibodies and Vascular Inflammation
  A.Rutgers, J.S.F. Sanders, J.W. Cohen Tervaert, C.G.M. Kallenberg
• 7. Neutrophils and Vascular Inflammation
  Matthew David Morgan and Caroline OS Savage
• 8. Cytokines and Vascular Inflammation
  Maria C Cid, Marc Corbera-Bellalta, Ester Planas-Rigol, Ester Lozano, Georgina Espígol-Frigolé, Ana García-Martínez, José Hernández-Rodríguez, Marta Segarra
• 9. Oxidative Stress and Vascular Inflammation
  David G. Harrison
• 10. Hemostasis and Vascular Inflammation
  Lawrence Leung and John Morser
• 11. Animal Models of Vasculitis
  Masato Nose
• 12. Arteries, Smooth Muscle Cells, and Genetic Causes of Thoracic Aortic Aneurysms
  Amy J. Reid and Dianna M. Milewicz
• 13. Innate Immunity in Atherosclerosis
  Shuang Chen, Prediman K. Shah and Moshe Arditi
• 14. Adaptive Immunity in Atherosclerosis
  Jan Nilsson

Section II. Primary Autoimmune Vascular Diseases

• 15. Historical Perspectives Vasculitis
  Eric L. Matteson
• 16. Approach to the Differential Diagnosis of Vasculitis
  Eamonn S. Molloy and Carol A. Langford
• 17. Imaging of medium and large vessels (CT/PET/MR)
  Thorsten Alexander Bley
• 18. Kawasaki disease
  Rae S.M. Yeung
• 19. Henoch-Schonlein Purpura
  Philip J. Hashkes and Alexandra Villa-Forte
• 20. Polyarteritis Nodosa
  Eli M. Miloslavsky and John H. Stone
• 21. Microscopic polyangiitis
  Coen Stegeman
• 22. Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
  Gary S. Hoffman, Carol A. Langford and Ulrich Specks
• 23. Churg–Strauss Syndrome (Eosinophilic Granulomatosis with Polyangiitis, EGPA)
  Christian Pagnoux and Loïc Guillevin
• 24. Giant cell arteritis
  Cornelia M. Weyand and Jörg J. Goronzy
• 25. Takayasu's arteritis
  Kathleen Maksimowicz-McKinnon and Gary S. Hoffman
• 26. Behçet's Syndrome
  Yusuf Yazici, Ismail Simsek and Hasan Yazici
• 27. Cogan's Syndrome
  Rex M. McCallum and E. William St. Clair
• 28. Idiopathic cryoglobulinemic vasculitides
  Benjamin Terrier and Patrice Cacoub
• 29. Primary central nervous system vasculitis
  Rula A. Hajj-Ali and Leonard H. Calabrese
• 30. Single organ vasculitis
  José Hernández-Rodríguez and Gary S. Hoffman
• 31. Primary cutaneous vasculitis
  Jeffrey P. Callen
• 32. Buerger's disease (thromboangiitis obliterans)
  Ahmet Ruchan Akar and M. Serkan Durdu

Section III. Secondary Causes of Vasculitis

• 33. Virus-associated vasculitides
  Dimitrios Vassilopoulos and Leonard H. Calabrese
• 34. Drug-induced vasculitis
  Peter A. Merkel
• 35. Rheumatoid vasculitis
  Kimberly P. Liang, Carl Turesson, Larry W. Moreland
• 36. Vasculopathy/Vasculitis and progressive systemic sclerosis
  Nezam Altorok, Omar R. Kahaly and Bashar Kahaleh
• 37. Vasculitis and Sjögren's syndrome
  George E. Fragoulis and Haralampos M. Moutsopoulos
• 38. Vasculitis in systemic lupus erythematosus
  Ricardo Garcia and Andras Perl
• 39. Vasculitis in the Idiopathic Inflammatory Myopathies
  Frederick W. Miller and Chester V. Oddis
• 40. Vasculitis and relapsing polychondritis
  Tanaz A. Kermani and Kenneth J. Warrington
• 41. Systemic Vasculitis in Sarcoidosis
  Alexandra Villa-Forte and Gary S. Hoffman
• 42. Vasculitis as a Paraneoplastic Syndrome and Direct Tumour Invasion of Vessels
  Claire E. Barber and Simon Carette

Section IV. Recognizing Risks and Treating Damage from Vasculitis

• 43. Cholesterol and Modifications of Cholesterol in Rheumatic Disorders
  Jan Willem Cohen Tervaert
• 44. Prevention and treatment of medical complications
  Atul Khasnis and Carol A. Langford
• 45. Ophthalmic Risks and Complications Aassociated with the Treatment of Systemic Vasculitis
  Steven Yeh and James T. Rosenbaum
• 46. Subglottic Stenosis of Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
  Rahul Seth and Daniel S. Alam
• 47. Sino-Nasal Manifestations of Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
  Daniel S. Alam, Rahul Seth, Raj Sindwani
• 48. Neurologic Damage of Vasculitis
  C. David Lin
• 49. Endstage Renal Disease and Vasculitis
  Kirsten de Groot and Charles Pusey
• 50. Cardiothoracic Surgery for Takayasu's Arteritis and Giant Cell Arteritis
  Turki Albacker and Lars Svensson
• 51. Peripheral Vascular Surgery for Takayasu's Arteritis and Giant Cell Arteritis
  Ravi R. Rajani and Vikram S. Kashyap

• Index